Source-grounded facts extracted from INSPIRE VETERINARY PARTNERS, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
“November 13, 2025, Inspire Veterinary Partners, Inc. (the “Company”) received a notice letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), for the prior 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). The Notice stated that the Company’s securities would be suspended from trading on The Nasdaq Capital Ma”
Material Agreements
INSPIRE VETERINARY PARTNERS, INC. entered into Cancellation and Exchange Agreement with Target Capital 1 LLC valued at $25,000 (effective 2026-01-14).
“On January 14, 2026, Inspire Veterinary Partners, Inc. (the “Company”), entered into a Cancellation and Exchange Agreement, (the “Agreement”) with Target Capital 1 LLC ( “Target”). Pursuant to the Agreement, the Company and Target agreed to cancel $25,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the “June Note”), in exchange for 2,500,000 shares of the Company’s Class A common stock, par value $0.0001 per share.”
Material Agreements
INSPIRE VETERINARY PARTNERS, INC. entered into securities purchase agreement with Manetto Hill Fund Series I LLC valued at up to an aggregate of $1,626,000 principal amount of convertible promissory notes (effective 2026-01-06).
“On January 6, 2026, effective as of December 31, 2025, Inspire Veterinary Partners, Inc. (the “Company”) entered into a securities purchase agreement with Manetto Hill Fund Series I LLC”
Debt Financings
INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of up to an aggregate of $1,626,000 principal amount of convertible promissory notes with Manetto Hill Fund Series I LLC.
“On January 6, 2026, effective as of December 31, 2025, Inspire Veterinary Partners, Inc. (the "Company") entered into a securities purchase agreement with Manetto Hill Fund Series I LLC, a Delaware limited liability company ("Manetto") whereby the Company may issue up to an aggregate of $1,626,000 principal amount of convertible promissory notes in one or more closings, subject to the terms and conditions set forth therein.”
Debt Financings
INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of $975,000 with Manetto Hill Fund Series I LLC at 10% per annum maturing December 31, 2026.
“On January 6, 2026, effective as of December 31, 2025, the Company issued to a secured convertible promissory note in the principal amount of $975,000 for a purchase price of $750,000 (the "Note").”
Listing & Compliance Notices
INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).
“November 13, 2025, Inspire Veterinary Partners, Inc. (the “Company”) received a notice letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share, for the prior 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). Further, the Notice stated that, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company was not eligible for any compliance period s”
Debt Financings
INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of $178,571,43 with Keystone Capital Partners, LLC and Seven Knots, LLC at 10% per annum maturing August 5, 2026.
“On November 5, 2025, Inspire Veterinary Partners, Inc. (the “Company”) issued Senior Convertible Promissory Notes to Keystone Capital Partners, LLC and Seven Knots, LLC (the “Investors”), each in the principal amount of $178,571,43 with an original issue discount of 30% such that the purchase price of each note was $125,000 (each a “Note” and together, the “Notes”). Each Note bears interest at a rate of 10% per annum, payable monthly, and matures on August 5, 2026, unless earlier converted or repaid in accordance with its terms.”
Auditor Changes
INSPIRE VETERINARY PARTNERS, INC. engaged M&K CPAS, PLLC as its auditor.
“Effective October 16, 2025, the Company appointed M&K CPAS, PLLC (“M&K”) as the independent registered public accounting firm to audit the Company’s consolidated financial statements as of and for the fiscal year ended December 31, 2025.”
Auditor Changes
INSPIRE VETERINARY PARTNERS, INC. dismissed Kreit & Chiu CPA LLP as its auditor.
“On October 16, 2025, Inspire Veterinary Partners, Inc. (the “Company”) dismissed Kreit & Chiu CPA LLP (“K&C”) as the Company’s independent registered public accounting firm.”
Governance Changes
INSPIRE VETERINARY PARTNERS, INC.: Filed Certificate of Designations establishing Series B Preferred Stock (effective 2025-07-29).
“On July 28, 2025, the Company filed the Certificate of Designations for the purpose of designating and establishing the Company’s Series B Preferred Stock. The Certificate of Designations was filed pursuant to the Securities Purchase Agreement. The Certificate of Designations became effective on July 29, 2025.”
M&A Transactions
INSPIRE VETERINARY PARTNERS, INC. completed an acquisition involving Suarez Enterprises, LLC for $1,132,000, payable in cash (closed 2025-06-05).
“structures and fixtures, and all intangible property owned by the Suarez Enterprises in connection with the land or improvements, if any, for an aggregate purchase price of $1,132,000, payable in cash. The foregoing description of the Real Estate Asset Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full”
M&A Transactions
INSPIRE VETERINARY PARTNERS, INC. completed an acquisition involving Joseph A. Suarez, D.V.M., P.A. for $925,000 plus the assumed liabilities (closed 2025-06-05).
“and together with the Seller, the “Seller Parties”) completed the acquisition of the Debary Animal Clinic. The aggregate purchase consideration for the Debary Animal Clinic was $925,000 plus the assumed liabilities described below, consisting of $832,500 to be paid in cash at the closing of the acquisition plus 54,734 restricted shares of the Company’s Class A”
Kimball Carr was appointed as Chairman of the Board at INSPIRE VETERINARY PARTNERS, INC..
“appointed Kimball Carr, our current Chief Executive Officer, as Chairman of the Board”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.